Hinge Health, Inc. income statement
In fiscal 2025, Hinge Health, Inc. reported revenue of $588m, up 50.6% on the year before, operating income of −$546m (a -92.9% margin) and net income of −$528m, or −$7.77 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|
| Revenue | 293 | 390 | 588 | 720 |
| Cost of revenue | 99 | 91 | 120 | 112 |
| Gross profit | 194 | 300 | 468 | 608 |
| Research and development | 110 | 101 | 368 | 129 |
| Selling and marketing | 148 | 167 | 317 | 273 |
| General and administrative | 67 | 64 | 330 | 112 |
| Operating income | −131 | −32 | −546 | 94 |
| Provision for credit losses | 5 | 5 | 3 | 2 |
| Income before tax | −109 | −11 | −527 | 111 |
| Income tax | −0 | 1 | 1 | 2 |
| Net income | −108 | −12 | −528 | 109 |
| Diluted EPS | −$2.08 | −$0.22 | −$7.77 | — |
| Diluted shares (average) | 52m | 54m | 55m | — |
| EBITDA | −125 | −26 | −541 | 97 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 101 | 117 | 124 | 139 | 154 | 171 | 182 | 213 |
| Cost of revenue | 21 | 21 | 24 | 41 | 28 | 27 | 28 | 29 |
| Gross profit | 79 | 96 | 100 | 98 | 126 | 144 | 154 | 184 |
| Research and development | 24 | 22 | 23 | 280 | 32 | 33 | 30 | 34 |
| Selling and marketing | 45 | 35 | 47 | 147 | 64 | 59 | 69 | 81 |
| General and administrative | 15 | 17 | 17 | 251 | 37 | 25 | 23 | 28 |
| Operating income | −4 | 21 | 13 | −581 | −6 | 27 | 32 | 40 |
| Provision for credit losses | 1 | 1 | 1 | 2 | 1 | −0 | 0 | 2 |
| Income before tax | 1 | 26 | 18 | −576 | −2 | 32 | 36 | 44 |
| Income tax | 1 | −1 | 1 | −0 | 0 | 0 | 1 | 1 |
| Net income | 0 | 27 | 17 | −576 | −2 | 32 | 35 | 44 |
| Diluted EPS | $0.02 | $4.02 | $2.62 | −$13.10 | −$0.02 | $2.11 | $0.41 | $0.52 |
| EBITDA | −3 | 22 | 14 | −580 | −6 | 28 | 33 | 41 |
Compare with peers
- Goodrx Holdings, Inc. income statement
- Doximity, Inc. income statement
- Phreesia, Inc. income statement
- Genedx Holdings Corp. income statement
- Omnicell, Inc. income statement
Head to head: GDRX vs HNGEDOCS vs HNGEHNGE vs PHR
More: Health Care Technology stocks compared, Health Care sector, rankings of US companies